Cabergoline, Pramipexole and Ropinirole Used as Monotherapy in Early Parkinson’s Disease: An Evidence-Based Comparison

By Inzelberg R.   Schechtman E.  

Drugs & Aging, Vol. 20, Iss. 11, 2003-01 ,pp. : 847-855

Adis International

Access to resources Recommend Favorite

Ropinirole in the treatment of Parkinson’s disease

By Zesiewicz T.A.   Hauser R.A.  

Expert Opinion on Investigational Drugs, Vol. 8, Iss. 5, 1999-05 ,pp. : 697-710

Informa Healthcare

Access to resources Recommend Favorite

Coenzyme Q10 for Patients with Parkinson's Disease: A Systematic Review and Meta-Analysis

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 15, Iss. 1, 2016-02 ,pp. : 45-53

Bentham Science Publishers

Access to resources Recommend Favorite

Rasagiline meta-analysis: a spotlight on clinical safety and adverse events when treating Parkinson's disease

By Solís-García del Pozo Julián   Mínguez-Mínguez Sara  

Expert Opinion on Drug Safety, Vol. 12, Iss. 4, 2013-07 ,pp. : 479-486

Informa Healthcare

Access to resources Recommend Favorite

A meta-analysis has identified a significantly increased risk of serious adverse events and treatment discontinuation in patients receiving telaprevir

By  

Reactions Weekly, Vol. 1, Iss. 1419, 2012-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite